Clinical trial
Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics
NCT00247689 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Methylphenidate Studies for Drug Abuse Vulnerability Molecular Genentics
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 22, 2004
- Completion date
- February 27, 2015
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
substance abuse